Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Jørgensen

Young High Risk Patients With Diffuse Large B-Cell Lymphoma Including BCL-2/Myc Double Hit Lymphomas Benefit From Dose-Dense Immunochemotherapy With Early CNS Prophylaxis

Hematological Oncology

English

Clinical Significance of T-Cell Exhaustion in Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

Related publications

Prophylaxis With High-Dose Methotrexate Significantly Reduces CNS Dissemination in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) and High-Risk CNS-IPI Score

Hematological Oncology

English

BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma

Sao Paulo Medical Journal

Medicine

2010

English

Combination of BCL-2 and MYC Protein Expression Improves High-Risk Stratification in Diffuse Large B-Cell Lymphoma

OncoTargets and Therapy

Oncology

Pharmacology

2015

English

The Double Hit Signature Identifies Double-Hit Diffuse Large B-Cell Lymphoma With Genetic Events Cryptic to FISH

English

Unfavorable Prognostic Impact of MYC Increased Copy Number (ICN) in Patients With Diffuse Large B-Cell (DLBCL) and High-Grade Lymphoma Treated With Immunochemotherapy

Hematological Oncology

English

Immunochemoradiotherapy or Immunochemotherapy Only in Patients With Extranonal Diffuse Large B-Cell Lymphoma of Stomach

Hematological Oncology

English

Double-Hit B-Cell Lymphomas

English

Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)

Hematological Oncology

English

Plasma Immunoprofiling of Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Nordic Lymphoma Group Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Jørgensen

Young High Risk Patients With Diffuse Large B-Cell Lymphoma Including BCL-2/Myc Double Hit Lymphomas Benefit From Dose-Dense Immunochemotherapy With Early CNS Prophylaxis

Clinical Significance of T-Cell Exhaustion in Patients With Diffuse Large B-Cell Lymphoma

Related publications

Prophylaxis With High-Dose Methotrexate Significantly Reduces CNS Dissemination in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) and High-Risk CNS-IPI Score

BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma

Combination of BCL-2 and MYC Protein Expression Improves High-Risk Stratification in Diffuse Large B-Cell Lymphoma

­­The Double Hit Signature Identifies Double-Hit Diffuse Large B-Cell Lymphoma With Genetic Events Cryptic to FISH

Unfavorable Prognostic Impact of MYC Increased Copy Number (ICN) in Patients With Diffuse Large B-Cell (DLBCL) and High-Grade Lymphoma Treated With Immunochemotherapy

Immunochemoradiotherapy or Immunochemotherapy Only in Patients With Extranonal Diffuse Large B-Cell Lymphoma of Stomach

Double-Hit B-Cell Lymphomas

Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)

Plasma Immunoprofiling of Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Nordic Lymphoma Group Study

The Double Hit Signature Identifies Double-Hit Diffuse Large B-Cell Lymphoma With Genetic Events Cryptic to FISH